Elections have consequences, and this year’s presidential and congressional elections certainly will have consequences for health and regulatory policy. Washington and the political media are abuzz speculating on what the Trump election and the new Republican majorities in the Senate and almost certainly the House will bring us, and what the changes mean for us as individuals, for the foods we eat and the medical products we use, and for the industries that make products regulated by the Food and Drug Administration (FDA)—which represent at least 20% of consumer spending.
We’re still very early in the process, but to try to put the evolving picture into perspective, here are 10 observations on the impact of the presidential election on FDA and health/regulatory policy more generally.
